GPs alongside oncologists key for melanoma outcomes

Source: News GP, September 2024

Drug therapies for the treatment of melanoma are advancing, and many now play a role for the treatment of earlier stage disease, according to new research.

Published in the latest edition of the Australian Journal of General Practice (AJGP), which focuses on skin cancer, the paper summarises the latest evidence base in melanoma care, with guidance for when GPs should refer patients to medical oncologists as part of the multidisciplinary team.

Breakthrough drug therapies, such as immune-checkpoint inhibitors (ICIs), and partnerships between GPs and oncologists have resulted in earlier treatment and reduced recurrence of melanoma after surgery, the authors highlight.
READ THE ORIGINAL FULL ARTICLE